Vivo Bio Tech Q2 FY27 Results: Net Profit ₹1.1 Cr, Up 22.2% YoY
Vivo Bio Tech Ltd reported revenue from operations of ₹17.2 Cr (+31.3% YoY) and net profit of ₹1.1 Cr (+22.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.1 Cr · +22.2% YoY
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Vivo Bio Tech Ltd reported revenue from operations of ₹17.2 Cr (+31.3% YoY) and net profit of ₹1.1 Cr (+22.2% YoY) for Q2 FY27.
Vivo Bio Tech has scheduled a board meeting for November 11, 2026, to consider unaudited standalone and consolidated results for the quarter ended September 30, 2026. The trading window stays closed until 48 hours after results declaration.
The company submitted its periodic shareholding pattern for the quarter ended September 30, 2026, disclosing its promoter and public shareholding as mandated by SEBI.
Vivo Bio Tech reports a fire at its Telangana research facility damaging labs, equipment, and samples. No casualties; damage under assessment with adequate insurance coverage in place.